Paper36980665
The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy?
Alsalloum A and 2 others. Cancers (Basel), 2023. Cited by 47 papers, by iCite.
Cite this record
ConductScience Library. The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy? Papers, record 36980665. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36980665
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy?
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 21-65-00004 | Russian Science Foundation (RSF) | PubMed |
Source PubMed
References68
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19088187 | Genome-wide analysis of cancer/testis gene expression. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/19088187 | PubMed |
| 2 | 16687489 | Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells. | Mol Cancer Res | 2006 | https://conductscience.org/library/papers/16687489 | PubMed |
| 3 | 10189127 | Expression of the MAGE gene family in human hepatocellular carcinoma. | Cancer | 1999 | https://conductscience.org/library/papers/10189127 | PubMed |
| 4 | 16299236 | Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer. | Clin Cancer Res | 2005 | https://conductscience.org/library/papers/16299236 | PubMed |
| 5 | 1840703 | A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. | Science | 1991 | https://conductscience.org/library/papers/1840703 | PubMed |
| 6 | 29763778 | MAGE-A antigens as targets for cancer immunotherapy. | Cancer Treat Rev | 2018 | https://conductscience.org/library/papers/29763778 | PubMed |
| 7 | 25315972 | High expression of MAGE-A9 correlates with unfavorable survival in hepatocellular carcinoma. | Sci Rep | 2014 | https://conductscience.org/library/papers/25315972 | PubMed |
| 8 | 10523621 | DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. | Mol Cell Biol | 1999 | https://conductscience.org/library/papers/10523621 | PubMed |
| 9 | 9679755 | Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer. | Int J Cancer | 1998 | https://conductscience.org/library/papers/9679755 | PubMed |
| 10 | 29908991 | MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial. | Lancet Oncol | 2018 | https://conductscience.org/library/papers/29908991 | PubMed |
| 11 | 30915277 | Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies. | Front Oncol | 2019 | https://conductscience.org/library/papers/30915277 | PubMed |
| 12 | 25363021 | Differential regulation of MAGE-A1 promoter activity by BORIS and Sp1, both interacting with the TATA binding protein. | BMC Cancer | 2014 | https://conductscience.org/library/papers/25363021 | PubMed |
| 13 | 27163739 | Isolation and Characterization of an HLA-DPB1*04: 01-restricted MAGE-A3 T-Cell Receptor for Cancer Immunotherapy. | J Immunother | 2016 | https://conductscience.org/library/papers/27163739 | PubMed |
| 14 | 25755744 | High expression of MAGE-A9 in tumor and stromal cells of non-small cell lung cancer was correlated with patient poor survival. | Int J Clin Exp Pathol | 2015 | https://conductscience.org/library/papers/25755744 | PubMed |
| 15 | 29177094 | Safety and immunogenicity of MAGE-A3 cancer immunotherapeutic with dacarbazine in patients with MAGE-A3-positive metastatic cutaneous melanoma: an open phase I/II study with a first assessment of a predictive gene signature. | ESMO Open | 2017 | https://conductscience.org/library/papers/29177094 | PubMed |
| 16 | 7672823 | Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene. | Immunogenetics | 1995 | https://conductscience.org/library/papers/7672823 | PubMed |
| 17 | 23926201 | Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells. | Sci Transl Med | 2013 | https://conductscience.org/library/papers/23926201 | PubMed |
| 18 | 12548548 | Cancer/testis-associated genes: identification, expression profile, and putative function. | J Cell Physiol | 2003 | https://conductscience.org/library/papers/12548548 | PubMed |
| 19 | 35372008 | Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors. | Front Oncol | 2022 | https://conductscience.org/library/papers/35372008 | PubMed |
| 20 | 19417017 | Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19417017 | PubMed |
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42971725 | Enhanced melanoma-specific cytotoxic T-cell expansion and the clinical outcomes with simlukafusp alfa and pembrolizumab following checkpoint inhibitor progression. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42971725 | PubMed |
| 42755095 | MAGEA Family Gene Expression Influences Survival in Intestinal-Type Gastric Cancer. | Cancer Med | 2026 | https://conductscience.org/library/papers/42755095 | PubMed |
| 42753002 | Cancer-Testis Antigens in Immuno Oncology Mechanisms Therapeutic Strategies and Clinical Perspectives. | J Immunol Res | 2026 | https://conductscience.org/library/papers/42753002 | PubMed |
| 42500564 | The Construction and Preclinical Evaluation of Antitumor Activity of a Novel MIgG-OXA ADC in Lung Adenocarcinoma. | Oncol Res | 2026 | https://conductscience.org/library/papers/42500564 | PubMed |
| 42121790 | A Novel Recombinant MAGE-B10-HSP110 Fusion Protein Enhances Innate and Adaptive Immune Responses in Mice: A Potential Vaccine Candidate for Canine Mammary Tumors. | Animals (Basel) | 2026 | https://conductscience.org/library/papers/42121790 | PubMed |
| 42079663 | Translational strategy to support the first-in-human study of a TCR-like T cell bispecific with an in vitro-based safety approach. | Front Immunol | 2026 | https://conductscience.org/library/papers/42079663 | PubMed |
| 42041682 | A Pan-Cancer Transcriptomic Signature for Conserved Molecular Programs Underlying Premalignant-Malignant Progression Across Common Carcinomas. | Dent J (Basel) | 2026 | https://conductscience.org/library/papers/42041682 | PubMed |
| 41426498 | Solid tumor rejection using personalized incompatible human leukocyte antigen (HLA) and blood group ABH antigens. | Explor Med | 2025 | https://conductscience.org/library/papers/41426498 | PubMed |
| 41309872 | In silico design of a multi-epitope vaccine against the triple negative breast cancer. | Sci Rep | 2025 | https://conductscience.org/library/papers/41309872 | PubMed |
| 41209563 | Advances in Tumor Antigen Vaccines: A New Frontier in Cancer Immunotherapy. | Int J Med Sci | 2025 | https://conductscience.org/library/papers/41209563 | PubMed |
| 41173834 | S100A9 enhances tumor immune suppression and cancer cell survival in small cell lung cancer. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/41173834 | PubMed |
| 41012179 | Messenger RNA and Plasmid DNA Vaccines for the Treatment of Cancer. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41012179 | PubMed |
| 40943226 | Comparison of Current Immunotherapy Approaches and Novel Anti-Cancer Vaccine Modalities for Clinical Application. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943226 | PubMed |
| 40721826 | Melanoma antigens in pediatric medulloblastoma contribute to tumor heterogeneity and species-specificity of group 3 tumors. | Acta Neuropathol Commun | 2025 | https://conductscience.org/library/papers/40721826 | PubMed |
| 40655139 | The multifaceted roles of mucins family in lung cancer: from prognostic biomarkers to promising targets. | Front Immunol | 2025 | https://conductscience.org/library/papers/40655139 | PubMed |
| 40631515 | An SNP-dependent cancer-testis antigenic epitope serves as a promising immunotherapeutic target for cancer. | Oncoimmunology | 2025 | https://conductscience.org/library/papers/40631515 | PubMed |
| 40625850 | Lung cancer vaccine strategies: exploring the spectrum from traditional to RNA-based platforms. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/40625850 | PubMed |
| 40535484 | Immunotherapy and liver transplantation for hepatocellular carcinoma: Current and future challenges. | World J Transplant | 2025 | https://conductscience.org/library/papers/40535484 | PubMed |
| 40473741 | Bioinformatics analysis of innovative multi-epitope vaccine utilizing MAGE-A, MAM-A, and Gal-3 for breast cancer management. | Sci Rep | 2025 | https://conductscience.org/library/papers/40473741 | PubMed |
| 40167762 | A new era of cancer immunotherapy: vaccines and miRNAs. | Cancer Immunol Immunother | 2025 | https://conductscience.org/library/papers/40167762 | PubMed |
Genes32
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36980665
GET https://conductscience.org/api/papers/v1/36980665/references?page=2